Abstract
Background: Seizure control (SC) is often poor in cases of magnetic resonance imaging- negative epilepsy after resection surgery.
Objective: This study aimed to evaluate the therapeutic efficacy of depth-electrode-guided stereotactic radiofrequency thermocoagulation (RFTC) applied to the amygdalohippocampal complex (AHC) for the treatment of patients with MRI-negative medial temporal lobe epilepsy.
Methods: A total of 62 cases with magnetic resonance imaging-negative medial temporal lobe epilepsy were retrospectively studied after the application of depth-electrode-guided RFTC to the AHC. Single-target coagulations were applied to all patients, and multi-target coagulations were applied to those patients who did not experience significant reductions in discharges after the first target ablation. Bilateral-target coagulations were applied to bilateral medial temporal lobe epilepsy patients, using single target ablation applied to each side.
Results: After 24-83 months of follow-up, 32/62 (51.61%) patients became seizure-free, and 35/62 (56.45%) patients reported significant reductions in seizure episodes. The total effective rate was 69.35% (43/62). No significant differences were observed for SC among the single-target, multi-target, and bilateral-target groups. However, a significant difference was observed for the reduction in epileptic discharges after coagulations between those patients who became seizure-free and those who did not. Magnetic resonance imaging-negative medial temporal lobe epilepsy patients can benefit from RFTC applied to the AHC. A significant reduction in epileptic discharges observed during operations after RFTC is applied may predict good SC.
Conclusion: RFTC applied to the AHC could be considered a promising method for the treatment of magnetic resonance imaging-negative medial temporal lobe epilepsy patients.
Keywords: Seizure control, amygdalohippocampal complex, medial temporal lobe epilepsy, MRI-negative epilepsy, radiofrequency thermocoagulation, predictor.
Graphical Abstract
[http://dx.doi.org/10.1111/j.1528-1157.1994.tb02471.x] [PMID: 8026397]
[http://dx.doi.org/10.1016/S0079-6123(02)35023-4] [PMID: 12143344]
[http://dx.doi.org/10.1111/j.1528-1157.1999.tb02013.x] [PMID: 10528937]
[http://dx.doi.org/10.1136/jnnp.20.1.11] [PMID: 13406589]
[http://dx.doi.org/10.1111/j.1528-1157.1997.tb01259.x] [PMID: 9579895]
[http://dx.doi.org/10.1212/01.wnl.0000335166.20451.88] [PMID: 19015488]
[http://dx.doi.org/10.1016/j.eplepsyres.2008.11.013] [PMID: 19135870]
[http://dx.doi.org/10.1111/j.1528-1167.2011.03048.x] [PMID: 21453360]
[http://dx.doi.org/10.1111/epi.12387] [PMID: 24116395]
[http://dx.doi.org/10.1684/epd.2017.0914] [PMID: 28637635]
[http://dx.doi.org/10.1007/978-3-7091-0179-7_4] [PMID: 21197608]
[http://dx.doi.org/10.1007/s00701-010-0637-2] [PMID: 20361215]
[http://dx.doi.org/10.1016/j.yebeh.2012.04.135] [PMID: 22687387]
[http://dx.doi.org/10.1111/j.1528-1167.2010.02720.x] [PMID: 21175607]
[http://dx.doi.org/10.1093/brain/awh257] [PMID: 15282217]
[http://dx.doi.org/10.1016/j.seizure.2011.12.003] [PMID: 22209542]
[http://dx.doi.org/10.1046/j.1528-1157.2001.042007954.x] [PMID: 11488900]
[http://dx.doi.org/10.1001/archneur.1963.00460070011001] [PMID: 13937583]
[http://dx.doi.org/10.1159/000098527] [PMID: 17228178]
[http://dx.doi.org/10.1016/S0140-6736(00)03600-X] [PMID: 11213111]
[http://dx.doi.org/10.1056/NEJMc1203204] [PMID: 22591307]